Overview

Singulair(R) In Asthma And Allergic Rhinitis (0476-383)

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Effectiveness of adding montelukast to inhaled corticosteroids in adult subjects with both uncontrolled asthma and allergic rhinitis.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast